Endotoxin Contamination in Wound Dressings Made of Natural Biomaterials

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 66, Issue 1, 2003, Pages 347-355

  Nakagawa, Y ^a   Murai, T ^a   Hasegawa, Chie ^a   Hirata, M ^b   Tsuchiya, T ^a   Yagami, T ^a   Haishima, Yuji ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b Research Division of Innate Immunity   (Japan)

Author keywords

Endotoxin; LAL test; Proinflammatory cytokine; Pyrogenicity; Wound dressing

Indexed keywords

BIOASSAY; BLOOD; CELLS; COLUMN CHROMATOGRAPHY; CONTAMINATION;

WOUND DRESSINGS;

BIOMATERIALS;

B 464; BIOMATERIAL; CALCIUM ALGINATE; CHITIN; COLLAGEN; CYTOKINE; ENDOTOXIN; ENDOTOXIN ANTAGONIST; INTERLEUKIN 6; LEUCINE; NATURAL PRODUCT; POLYLEUCINE; PYROGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; DRUG DERIVATIVE; LIPID A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM CONTAMINATION; BLOOD CELL; CELL LINE MM6 CA8; CONTROLLED STUDY; CYTOKINE RELEASE; DIAGNOSTIC TEST; FEVER; GEL CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIMULUS LYSATE TEST; MONOCYTE; NONHUMAN; RABBIT; WOUND DRESSING; ANIMAL; BANDAGE; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG CONTAMINATION; DRUG EFFECT; IMMUNOLOGY; IN VITRO STUDY; MALE; MATERIALS TESTING; METABOLISM;

ANIMALS; BANDAGES; BIOCOMPATIBLE MATERIALS; BLOOD CELLS; DRUG CONTAMINATION; ENDOTOXINS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LIMULUS TEST; LIPID A; MALE; MATERIALS TESTING; MONOCYTES; PYROGENS; RABBITS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0347384138     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.b.10020     Document Type: Article

References (38)

1. Rietschel ET, Brade L, Schade U, Seydel U, Zähringer U, Lindner B, Morgan A, Kulshin V A, Haishima Y, Holst O, Rohrscheide-Andrzewski E, Ulmer J D, Brade H. Chemical structure and biological activity of lipopolysaccharides. In: Baumgartner JD, Calandra T, Cartlet J, editors. Endotoxin from pathophysiology to therapeutic approaches. Paris: Flammarion Medicine-Sciences; 1990. pp 5-18.
2. Shimodaira A, Kazama M, Matsumoto S. Studies on fever-producing substances (III) pyrogenicity and physical chemical experiments on disposable transfusion assemblies. Tokyo Metrop Res Lab Public Health Annu Rep 1970;22:147-152.
3. Rietschel ET, Mayer H, Wollenweber HW, Zähringer U, Lüderitz O, Westphal O, Brade H. Bacterial lipopolysaccharides and their lipid A component. In: Homma JY, Kanegasaki S, Lüderitz U, Shiba T, Westphal O, editors. Bacterial endotoxin: Chemical, biological and clinical aspects. Basel: Verlag Chemie; 1984. pp 11-22.
4. Rietschel ET, Brade H. Bacterial endotoxins. Scientific American, August 1992. pp 26-33.
5. Morrison DC, Dinarello CA, Munford RS, Natanson C, Danner R, Pollack M, Spitzer JJ, Spitzer RJ, Ulevitch RJ, Vogel S N, Mcsweegan E. Current status of bacterial endotoxins. ASM News 1994;60:479-484.
6. Peiró SA, Kulander L, Eriksson Ö. Quantitative determination of endotoxins on surgical gloves. J Hosp Infect 1990;16:167-172.
7. Thomas A, Harding KG, Moore K. Alginates from wound dressings activate human macrophages to secrete tumor necrosis factor-α. Biomater 2000;21:1797-1802.
8. Charous BL, Beezhold DH, Adler WH, Hamilton RG. Endotoxin: A role on latex allergy? Ann Allergy Asthma Immunol 1997;79:277-280.
9. Shmunes E, Darby T. Contact dermatitis due to endotoxin in irradiated latex gloves. Contact Dermatitis 1984;10:240-244.
10. Williams PB, Halsey JF. Endotoxin as a factor in adverse reaction to latex gloves. Ann Allergy Asthma Immunol 1997; 79:303-310.
11. Haishima Y, Murai T, Nakagawa Y, Hirata M, Yagami T, Nakamura A. Chemical and biological evaluation of endotoxin contamination on natural rubber latex products. J Biomed Mater Res 2001;55:424-432.
12. Nakagawa Y, Maeda H, Murai T. Evaluation of the in-vitro pyrogen test system based on proinflammatory cytokine release from human monocytic cells; comparison with a human whole blood culture test system and with the rabbit pyrogen test. Clin Diagn Lab Immunol 2002;9:588-597.
13. Adam O, Vercellone A, Paul F, Monsan P, Puzo G. A nondegradative route the removal of endotoxin from exopolysaccharides. Anal Biochem 1995;225:321-327.
14. Savelkoul HFJ, Vossen Ann CTM, Breedland EG, Tibbe GJM. Semi-preparative purification and validation of monoclonal antibodies for immunotherapy in mice. J Immunol Methods 1994; 172:33-42.
15. Warner SJC, Mitchell D, Savage N, Mcclain E. Dose-dependent reduction of lipopolysaccharide pyrogenicity by polymyxin B. Biochem Pharmacol 1985;34:3995-3998.
16. Soejima K, Ishizaka A, Urano T, Sayama K, Sakamaki F, Nakamura H, Terashima T, Waki Y, Tasaka S, Fujishima S, Kawata T, Christ W J, Kanazawa M. Protective effect of B464, a lipid A analog, on endotoxin-induced cellular responses and acute lung injury. Am J Respir Crit Care Med 1996;154:900-906.
17. Nakamura Y, Murai T, Ogawa Y. Effect of in vitro and in vivo administration of dexamethasone on rat macrophage functions: comparison between alveolar and peritoneal macrophages. Eur Respir J 1996;9:301-306.
18. Suffredini AF, Hochstein HD, Mcmahon FG. Dose-related inflammatory effects of intravenous endotoxin in humans: evaluation of a new clinical lot of Escherichia coli O: 113 endotoxin. J Infect Dis 1999;179:1278-1282.
19. Van Deventer SJH, Büller HR, ten Cate JW, Aarden LA, Hack C E, Sturk A. Experimental endotoxin in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 1990;76:2520-2526.
20. Weary M, Iii FP. A manufacturer's guide to depyrogenation. Biopharm 1988:22-29.
21. Pfeiffer M. Testing medical disposables using the imulus moebocyte lysate (LAL) test. Med Device Technol 1990;1:37-41.
22. Holmdahl L, Chegini N. Endotoxin and particulate matter on surgical gloves. J Long-Term Effects Med Implants 1997;7: 225-234.
23. Yamamoto K, Noishiki Y, Mo M, Kondo J, Matsumoto A. Unusual inflammatory responses around a collagen-impregnated vascular prosthesis. Artif Organs 1993;17:1010-1016.
24. Klöck G, Pfeffermann A, Ryser C, Gröhn P, Kuttler B, Hahn HJ, Zimmermann U. Biocompatibility of mannuronic acid-rich alginates. Biomaterials 1997:18:707-713.
25. Hochstein HD, Fitsgerald EA, McMahon FG, Vargas R. Properties of US Standard Endotoxin (EC-5) in human male volunteers. J Endotoxin Res 1994;1:52-56.
26. Adachi Y, Okazaki M, Ohno N, Yadomae T. Enhancement of cytokine production by macrophages stimulated with (1, 3)-β-D-glucan. Biol Pharm Bull 1994;17:1554-1560.
27. Fahmi H, Ancuta P, Perrier S, Chaby R. Preexposure of mouse peritoneal macrophages to lipopolysaccharide and other stimuli enhances the nitric oxide. Inflamm Res 1996;45:347-353.
28. Iwanaga S. The limulus clotting reaction. Curr Opin Immunol 1993;5:74-72.
29. Pearson III FC, Weary ME, Bohon J, Dabbah R. Relative potency of "environmental" endotoxin as measured by the limulus amebocyte lysate test and the USP rabbit pyrogen test. In: Endotoxins and their detection with the Limulus Amebocyte Lysate test. New York: Alan R. Liss; 1982. pp 65-77.
30. Eperon S, De Groote D, Werner-Felmayer G, Jungi TW. Human monovytoid cell lines as indicators of endotoxin: Comparison with rabbit pyrogen and Limulus amoebocyte lysate assay. J Immunol Meth 1997;207:135-145.
31. Moesby L, Jensen S, Hansen EW, Christensen JD. A comparative study of Mono Mac 6 cells, isolated mononuclear cells and Limulus amoebocyte lysate assay in pyrogen testing. Int J Pharmaceut 1999;191:141-149.
32. Keene WR, Silberman HR, Landy M, Strelecky KA. Observations on the pyrogenic response and its application to the bioassay of endotoxin. J Clin Invest 1961;40:295-301.
33. Greisman SE, Hornick RB. Comparative pyrogenic reactivity of rabbit and man to bacterial endotoxin. Proc Soc Exp Biol Med 1969;131:1154-1158.
34. Dinarello CA. Cytokines as endogenous pyrogens. J Infect Dis 1999;179(Suppl 2):S294-304.
35. Luheshi G, Rothwell N. Cytokines and fever. Int Arch Allergy Immunol 1996;109:301-307.
36. De Groote D, Zangerle PF, Gevaert Y, Fassotte MF, Beguin Y, Noizat-Pirenne F, Pirenne J, Gathy R, Lopez M, Dehart I, Igot D, Baudrihaye M, Delacroix D, Franchimont P. Direct stimulation of cytokines (IL-1β, TNFα, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 1992;4:239-248.
37. Golenbock DT, Hampton RY, Qureshi N, Takayama K, Raetz CRH. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J Biol Chem 1991;266: 19490-19498.
38. Tanamoto K, Azumi S. Salmonella-type heptaacylated lipid A is inactive and acts as an antagonist of lipopolysaccharide action on human line cells. J Immunol 2000;164:3149-3156.